Stockreport

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

Pliant Therapeutics, Inc.  (PLRX) 
PDF Oncology program advancing with data expected in the fourth quarter 2025 BEACON-IPF close out activities to be completed in the fourth quarter 2025 SOUTH SAN FRANCISCO [Read more]